Impulse Related Compulsive Behavior

Aripiprazole (Abilify), a second-generation antipsychotic indicated for the treatment of schizophrenia and bipolar disorder, as well as agitation associated with either of those conditions and as an adjunct therapy for major depression, has recently been linked to a an increase in impulse-related compulsive behaviors.

Read the entire article here:


Copyright AudibleRx (TM), all rights reserved.